O	0	4	Dead
O	5	10	space
O	11	18	closure
O	19	23	with
B-intervention	24	32	quilting
I-intervention	33	39	suture
O	40	46	versus
B-control	47	59	conventional
I-control	60	67	closure
O	68	72	with
O	73	81	drainage
O	82	85	for
O	86	89	the
O	90	100	prevention
O	101	103	of
B-condition	104	110	seroma
O	111	116	after
O	117	127	mastectomy
O	128	131	for
O	132	138	breast
O	139	145	cancer
O	146	147	(
O	147	156	QUISERMAS
O	156	157	)
O	157	158	:
O	159	167	protocol
O	168	171	for
O	172	173	a
O	174	185	multicentre
O	186	196	randomised
O	197	207	controlled
O	208	213	trial
O	213	214	.

O	215	228	Postoperative
O	229	234	wound
O	235	241	seroma
O	242	244	is
O	245	251	common
O	252	257	after
O	258	268	mastectomy
O	268	269	.

O	270	274	This
O	275	287	complication
O	288	290	is
O	291	301	associated
O	302	306	with
O	307	318	significant
O	319	325	impact
O	326	328	on
O	329	336	patient
O	337	345	outcomes
O	346	349	and
O	350	360	healthcare
O	361	366	costs
O	366	367	.

O	368	371	The
O	372	379	optimal
O	380	387	closure
O	388	396	approach
O	397	400	for
O	401	407	seroma
O	408	418	prevention
O	419	426	remains
O	427	434	unknown
O	435	438	but
O	439	443	some
O	444	452	evidence
O	453	461	suggests
O	462	466	that
O	467	475	quilting
O	476	482	suture
O	483	485	of
O	486	489	the
O	490	494	dead
O	495	500	space
O	501	506	could
O	507	512	lower
O	513	516	the
O	517	526	incidence
O	527	529	of
O	530	536	seroma
O	536	537	.

O	538	541	The
O	542	545	aim
O	546	548	of
O	549	553	this
O	554	559	trial
O	560	562	is
O	563	565	to
O	566	573	compare
O	574	580	seroma
O	581	590	formation
O	591	596	using
O	597	605	quilting
O	606	612	suture
O	613	619	versus
O	620	632	conventional
O	633	640	closure
O	641	645	with
O	646	654	drainage
O	655	657	in
B-eligibility	658	666	patients
I-eligibility	667	677	undergoing
I-eligibility	678	688	mastectomy
O	688	689	.

O	690	694	This
O	695	697	is
O	698	699	a
O	700	711	multicentre
O	711	712	,
O	713	724	superiority
O	724	725	,
O	726	736	randomised
O	737	747	controlled
O	748	753	trial
O	754	756	in
B-eligibility	757	762	women
I-eligibility	763	773	undergoing
I-eligibility	774	784	mastectomy
I-eligibility	785	789	with
I-eligibility	790	792	or
I-eligibility	793	800	without
I-eligibility	801	809	axillary
I-eligibility	810	821	involvement
O	821	822	.

O	823	832	Exclusion
O	833	841	criteria
O	842	849	include
O	850	860	indication
O	861	863	of
O	864	873	bilateral
O	874	884	mastectomy
O	885	887	or
O	888	897	immediate
O	898	912	reconstruction
O	913	916	and
O	917	920	any
O	921	929	physical
O	930	932	or
O	933	944	psychiatric
O	945	954	condition
O	955	959	that
O	960	965	could
O	966	972	impair
O	973	980	patient
O	980	981	'
O	981	982	s
O	983	990	ability
O	991	993	to
O	994	1003	cooperate
O	1004	1008	with
O	1009	1022	postoperative
O	1023	1027	data
O	1028	1038	collection
O	1039	1041	or
O	1042	1046	that
O	1047	1049	do
O	1050	1053	not
O	1054	1059	allow
O	1060	1062	an
O	1063	1071	informed
O	1072	1079	consent
O	1079	1080	.

B-total-participants	1081	1084	320
O	1085	1097	participants
O	1098	1102	will
O	1103	1105	be
O	1106	1116	randomised
O	1117	1119	in
O	1120	1121	a
O	1122	1123	1
O	1123	1124	:
O	1124	1125	1
O	1126	1131	ratio
O	1132	1134	to
O	1135	1142	receive
O	1143	1149	either
O	1150	1158	quilting
O	1159	1165	suture
O	1166	1168	or
O	1169	1181	conventional
O	1182	1187	wound
O	1188	1195	closure
O	1196	1200	with
O	1201	1206	drain
O	1206	1207	.

O	1208	1211	The
O	1212	1219	primary
O	1220	1227	outcome
O	1228	1230	is
B-outcome-Measure	1231	1237	seroma
I-outcome-Measure	1238	1247	requiring
I-outcome-Measure	1248	1254	either
I-outcome-Measure	1255	1265	aspiration
I-outcome-Measure	1266	1268	or
I-outcome-Measure	1269	1277	surgical
I-outcome-Measure	1278	1290	intervention
O	1291	1297	within
O	1298	1300	21
O	1301	1305	days
O	1306	1315	following
O	1316	1326	mastectomy
O	1326	1327	.

O	1328	1337	Secondary
O	1338	1346	outcomes
O	1347	1354	include
B-outcome-Measure	1355	1361	seroma
I-outcome-Measure	1362	1372	regardless
I-outcome-Measure	1373	1375	of
I-outcome-Measure	1376	1383	whether
I-outcome-Measure	1384	1386	or
I-outcome-Measure	1387	1390	not
I-outcome-Measure	1391	1393	it
I-outcome-Measure	1394	1402	requires
I-outcome-Measure	1403	1405	an
I-outcome-Measure	1406	1418	intervention
O	1418	1419	,
B-outcome-Measure	1420	1428	surgical
I-outcome-Measure	1429	1433	site
I-outcome-Measure	1434	1443	infection
O	1443	1444	,
B-outcome-Measure	1445	1449	pain
I-outcome-Measure	1450	1455	score
O	1455	1456	,
B-outcome-Measure	1457	1465	cosmetic
I-outcome-Measure	1466	1472	result
O	1472	1473	,
B-outcome-Measure	1474	1481	patient
I-outcome-Measure	1481	1482	'
I-outcome-Measure	1482	1483	s
I-outcome-Measure	1484	1491	quality
I-outcome-Measure	1492	1494	of
I-outcome-Measure	1495	1499	life
O	1499	1500	,
B-outcome-Measure	1501	1506	costs
O	1507	1510	and
B-outcome-Measure	1511	1515	cost
I-outcome-Measure	1515	1516	-
I-outcome-Measure	1516	1529	effectiveness
O	1529	1530	.

O	1531	1534	The
O	1535	1542	primary
O	1543	1551	analysis
O	1552	1556	will
O	1557	1559	be
O	1560	1562	an
O	1563	1572	intention
O	1572	1573	-
O	1573	1575	to
O	1576	1581	treat
O	1582	1590	analysis
O	1591	1600	performed
O	1601	1605	with
O	1606	1607	a
O	1608	1609	Ï‡
O	1609	1610	(
O	1610	1611	2
O	1611	1612	)
O	1613	1617	test
O	1618	1619	(
O	1619	1621	or
O	1622	1628	Fisher
O	1628	1629	'
O	1629	1630	s
O	1631	1636	exact
O	1637	1641	test
O	1641	1642	)
O	1642	1643	.

O	1644	1651	Written
O	1652	1660	informed
O	1661	1668	consent
O	1669	1673	will
O	1674	1676	be
O	1677	1685	obtained
O	1686	1690	from
O	1691	1694	all
O	1695	1707	participants
O	1707	1708	.

O	1709	1713	This
O	1714	1719	study
O	1720	1723	was
O	1724	1732	approved
O	1733	1735	by
O	1736	1741	Tours
O	1742	1750	Research
O	1751	1757	ethics
O	1758	1767	committee
O	1768	1769	(
O	1769	1772	CPP
O	1773	1778	TOURS
O	1778	1779	-
O	1779	1785	Region
O	1786	1792	Centre
O	1792	1793	-
O	1793	1798	Ouest
O	1799	1800	1
O	1800	1801	,
O	1802	1806	2014
O	1806	1807	-
O	1807	1810	R20
O	1810	1811	,
O	1812	1814	16
O	1815	1823	December
O	1824	1828	2014
O	1828	1829	)
O	1829	1830	.

O	1831	1836	Study
O	1837	1845	findings
O	1846	1850	will
O	1851	1853	be
O	1854	1863	published
O	1864	1866	in
O	1867	1871	peer
O	1871	1872	-
O	1872	1880	reviewed
O	1881	1889	journals
O	1890	1893	and
O	1894	1903	presented
O	1904	1906	at
O	1907	1915	relevant
O	1916	1924	national
O	1925	1928	and
O	1929	1942	international
O	1943	1949	breast
O	1950	1956	cancer
O	1957	1968	conferences
O	1968	1969	.

O	1970	1981	NCT02263651
O	1981	1982	.
